Web Team 24/10/2026 Web Team 24/10/2026

Tarlatamab plus durvalumab extends survival in extensive-stage small cell lung cancer

Web Team 23/10/2026 Web Team 23/10/2026

Personalised mRNA cancer vaccine: what the INTerpath-001 results mean for lung cancer

Web Team 23/08/2026 Web Team 23/08/2026

PhD research uncovers new cell population that may help lung cancer suppress the immune system

Web Team 20/08/2026 Web Team 20/08/2026

Personalised cancer vaccine succeeds in Phase 3: what could it mean for lung cancer?

Web Team 19/07/2026 Web Team 19/07/2026

BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox

Web Team 07/07/2026 Web Team 07/07/2026

CAR T Cells and Lung Cancer: Could This Immunotherapy Become a Future Treatment?

Web Team 04/07/2026 Web Team 04/07/2026

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

Web Team 01/07/2026 Web Team 01/07/2026

England catches up on cemiplimab for advanced lung cancer

Web Team 11/06/2026 Web Team 11/06/2026

What Could a New Iron Discovery Mean for Lung Cancer Immunotherapy?

New research published in Nature Cancer has identified iron accumulation as a trigger for the destruction of CAR-T immune cells. We explore what this unexpected finding could mean for the future of lung cancer treatment.

Web Team 04/05/2026 Web Team 04/05/2026

What is subcutaneous pembrolizumab and what does the NHS rollout mean for people living with lung cancer in Europe?

Web Team 31/03/2026 Web Team 31/03/2026

EMA recommends tarlatamab for relapsed extensive-stage SCLC

Web Team 26/02/2026 Web Team 26/02/2026

Lung cancer, immunotherapy and the gut microbiome

Tarlatamab plus durvalumab extends survival in extensive-stage small cell lung cancer

Personalised mRNA cancer vaccine: what the INTerpath-001 results mean for lung cancer

PhD research uncovers new cell population that may help lung cancer suppress the immune system

Personalised cancer vaccine succeeds in Phase 3: what could it mean for lung cancer?

BMI, the Gut Microbiome and Immunotherapy: New Nature Study Explores the Obesity Paradox

CAR T Cells and Lung Cancer: Could This Immunotherapy Become a Future Treatment?

The Microbiome and Lung Cancer: How Gut Bacteria Could Change Treatment

England catches up on cemiplimab for advanced lung cancer

What Could a New Iron Discovery Mean for Lung Cancer Immunotherapy?

What is subcutaneous pembrolizumab and what does the NHS rollout mean for people living with lung cancer in Europe?

EMA recommends tarlatamab for relapsed extensive-stage SCLC

Lung cancer, immunotherapy and the gut microbiome

With Thanks to Our Supporters

Connect with us on LinkedIn

Stay in the loop